Champions Oncology Inc. (CSBR)
NASDAQ: CSBR
· Real-Time Price · USD
6.53
0.01 (0.15%)
At close: Aug 15, 2025, 3:59 PM
6.52
-0.15%
After-hours: Aug 15, 2025, 04:00 PM EDT
Champions Oncology Cash Flow Statement
Financials in USD. Fiscal
year is
May - April.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 |
Net Income | 4.5M | 728K | 1.31M | -109K | -2.53M | -2.07M | -2.57M | -2.56M | -2.44M | -16K | -319K | -344K | 787K | 277K | -172K | -482K | 740K | 1K | 75K |
Depreciation & Amortization | 398K | 399K | 449K | 457K | 1.26M | 484K | 445K | 583K | 575K | 560K | 528K | 568K | 396K | 346K | 317K | 303K | 297K | 307K | 277K |
Stock-Based Compensation | 256K | 9K | 258K | 263K | 379K | 53K | 423K | 208K | 331K | 119K | 206K | 188K | 310K | 134K | 280K | 161K | 232K | 85K | 120K |
Other Working Capital | n/a | 1.93M | -1.93M | -2.48M | 403K | 1.82M | -1.63M | 2.81M | 2.24M | -124K | -706K | 1.88M | 2.57M | 651K | -775K | -360K | 428K | 519K | -146K |
Other Non-Cash Items | -4.66M | -3.35M | 218K | 2.73M | 935K | 232K | 270K | 135K | 228K | 403K | 269K | 426K | 16K | 274K | 245K | 172K | 147K | 71K | -67K |
Deferred Income Tax | n/a | n/a | n/a | 1.04M | -1.34M | 137K | 162K | 919K | n/a | n/a | n/a | n/a | n/a | 39K | 74K | n/a | n/a | 130K | -81K |
Change in Working Capital | n/a | 1.93M | -1.93M | -3.23M | 375K | 1.75M | -2.73M | 7K | 2.88M | 2.22M | -879K | -42K | 2.75M | 158K | -528K | -2.13M | -1.28M | 285K | -1.04M |
Operating Cash Flow | 490K | -283K | 311K | -1.82M | -919K | 589K | -3.99M | -709K | 1.57M | 3.29M | -195K | 796K | 4.26M | 1.23M | 216K | -1.98M | 135K | 879K | -715K |
Capital Expenditures | -42K | -94K | n/a | 111K | -126K | -153K | -668K | -760K | -754K | -604K | -754K | -506K | -405K | -566K | -907K | -854K | -1.2M | -506K | -718K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 20K | n/a | n/a | 92K |
Investing Cash Flow | -42K | -94K | n/a | 111K | -126K | -153K | -668K | -760K | -754K | -604K | -754K | -506K | -405K | -566K | -907K | -834K | -1.2M | -506K | -626K |
Debt Repayment | -38K | -37K | -37K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K | -58K | -57K | -58K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | -32K | -602K | -74K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 38K | 276K | n/a | -146K | n/a | 240K | 12K | -75K | n/a | 86K | n/a | 16K | 68K | 121K | 2K | 73K | 2K | 1.29M | n/a |
Financial Cash Flow | n/a | 239K | -37K | -145K | n/a | 208K | -590K | -75K | n/a | 86K | n/a | 16K | 68K | 121K | 2K | 72K | -56K | 1.24M | -58K |
Net Cash Flow | 448K | -138K | 274K | -1.85M | -1.04M | 644K | -5.25M | -1.54M | 819K | 2.77M | -949K | 306K | 3.92M | 783K | -689K | -2.74M | -1.12M | 1.61M | -1.4M |
Free Cash Flow | 448K | -377K | 311K | -1.71M | -1.04M | 436K | -4.66M | -1.47M | 819K | 2.68M | -949K | 290K | 3.85M | 662K | -691K | -2.83M | -1.07M | 373K | -1.43M |